|
| | 104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026
HB3759 Introduced 2/18/2025, by Rep. Robert "Bob" Rita SYNOPSIS AS INTRODUCED:
| | 410 ILCS 620/3 | from Ch. 56 1/2, par. 503 | 410 ILCS 620/3.21a new | |
| Amends the Illinois Food, Drug and Cosmetic Act. Provides that it is a violation of the Act to contract to delay the entry of a drug into the marketplace. Makes a corresponding change. |
| |
| | A BILL FOR |
|
|
| | HB3759 | | LRB104 10676 BDA 20755 b |
|
|
| 1 | | AN ACT concerning health.
|
| 2 | | Be it enacted by the People of the State of Illinois, |
| 3 | | represented in the General Assembly:
|
| 4 | | Section 5. The Illinois Food, Drug and Cosmetic Act is |
| 5 | | amended by changing Section 3 and by adding Section 3.21a as |
| 6 | | follows:
|
| 7 | | (410 ILCS 620/3) (from Ch. 56 1/2, par. 503) |
| 8 | | Sec. 3. The enumerated acts in Sections 3.1 through 3.21a |
| 9 | | 3.21 and the causing thereof are prohibited in this State. |
| 10 | | (Source: P.A. 84-891.)
|
| 11 | | (410 ILCS 620/3.21a new) |
| 12 | | Sec. 3.21a. Contracting to delay the entry of a drug into |
| 13 | | the marketplace. |